본문 바로가기
KERD
논문KCI 등재

A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Osteosarcoma (OS) is one of the most common malignant primary bone tumors and NF-κB appears to play acausative role, but the mechanisms are poorly understood. OS is one of the pleomorphic, highly metastasized and invasiveneoplasm which is capable to generate osteoid, osteoclast and osteoblast matrix. Its high incidence has been reported inadolescent and children. Cell signal cascade is the pivotal functional mechanism acquired during the differentiation,proliferation, growth and survival of the cells in neoplasm including OS. The major limitation to the success of chemotherapyin OS is the development of multidrug resistance (MDR). Answers to all such queries might come from the knock-inexperiments in which the combined approach of miRNAs with NF-κB pathway is put into use. Abnormal miRNAs canmodulate several epigenetical switching as a hallmark of number of diseases via different cell signaling. Studies on miRNAshave opened up the new avenues for both the diagnosis and treatment of cancers including OS. Collectively, through thepresent study an attempt has been made to establish a new systematic approach for the investigation of microRNAs, biophysiologicalfactors and their target pairs with NF-κB to ameliorate oncogenesis with the “bridge between miRNAs and NF-κB”. The application of NF-κB inhibitors in combination with miRNAs is expected to result in a more efficient killing of thecancer stem cells and a slower or less likely recurrence of cancer.

Abstract

Osteosarcoma (OS) is one of the most common malignant primary bone tumors and NF-κB appears to play acausative role, but the mechanisms are poorly understood. OS is one of the pleomorphic, highly metastasized and invasiveneoplasm which is capable to generate osteoid, osteoclast and osteoblast matrix. Its high incidence has been reported inadolescent and children. Cell signal cascade is the pivotal functional mechanism acquired during the differentiation,proliferation, growth and survival of the cells in neoplasm including OS. The major limitation to the success of chemotherapyin OS is the development of multidrug resistance (MDR). Answers to all such queries might come from the knock-inexperiments in which the combined approach of miRNAs with NF-κB pathway is put into use. Abnormal miRNAs canmodulate several epigenetical switching as a hallmark of number of diseases via different cell signaling. Studies on miRNAshave opened up the new avenues for both the diagnosis and treatment of cancers including OS. Collectively, through thepresent study an attempt has been made to establish a new systematic approach for the investigation of microRNAs, biophysiologicalfactors and their target pairs with NF-κB to ameliorate oncogenesis with the “bridge between miRNAs and NF-κB”. The application of NF-κB inhibitors in combination with miRNAs is expected to result in a more efficient killing of thecancer stem cells and a slower or less likely recurrence of cancer.

참고문헌 (82)

  1. Abbott DW, "The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO", Curr Biol, 14, pp.2217~2227 (2004)
  2. "American Cancer Society OS: Overview" (2013)[URL]
  3. Baker RG, "NF-κB, Inflammation, and metabolic disease", Cell Metab, 13, pp.11~22 (2011)
  4. Baritaki S, "Viral infection and cancer:the NF-kappaB", Snail, Crit Rev Immunol, pp.2010, 30[DOI]
  5. Beristain AG, "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells", J Cell Sci, 125, pp.943~955 (2012)
  6. Broadhead ML, "The molecular pathogenesis of osteosarcoma:A review", Sarcoma, 2011, pp.1~12 (2011)
  7. Chen F, "Is NF-κB a culprit in type 2 diabetes?", Biochem Biophys Res Commun, 332, pp.1~3 (2005)
  8. Chen L, "MiR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1", 2-ERK1, FEBS Lett, pp.2013, 587[DOI]
  9. Chen X, "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", Cell Res, 18, pp.997~1006 (2008)
  10. Davis BN, "Regulation of MicroRNA Biogenesis:A miRiad of mechanisms", Cell Commun Signal, 7, pp.1~22 (2009)
  11. Duan Z, "MicroRNA-199a-3p is down regulated in human osteosarcoma and regulates cell proliferation and migration", Mol Cancer Ther, 10, pp.1337~1345 (2011)
  12. Esquela-Kerscher A, "Oncomirs-microRNAs with a role in cancer", Nat Rev Cancer, (4), pp.259~269 (2006)
  13. Fan L, "MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells", Acta Biochim Biophys Sin (Shanghai), 44, pp.407~414 (2012)
  14. Felx M, "Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-κB in human Osteosarcoma", Clin Sci (Lond), 110, pp.645~654 (2006)
  15. Geng S, "The tumor supperssor role of miR-124 in osteosarcoma", PLos one, 9, pp.e91566~ (2014)
  16. Hayden MS, "Shared principles in NF-κB signaling", Cell, 132, pp.344~362 (2008)
  17. He C, "Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples", Biochem Biophys Res Commun, 388, pp.35~40 (2009)
  18. Hoesel B, "The complexity of NF-κB signaling in inflammation and cancer", Mol Cancer, 12, pp.1~15 (2013)
  19. Huxford T, "A structural guide to proteins of the NF-kappaB signaling module", Cold Spring Harb Perspect Biol, 1, pp.1~16 (2009)
  20. Iliopoulos D, "An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation", Cell, 139, pp.693~706 (2009)
  21. Jin J, "MiRNA-218inhibits OS cell migration and invasion by downregulating of TIAM1, MMP2 and MMP9", Asian Pac J Cancer Prev, 14, pp.3681~3684 (2013)
  22. Kaltschmidt B, "NF-κB in the nervous system", Cold Spring Harb Perspect Biol, 1, pp.1~13 (2009)
  23. Kaltschmidt B, "Signaling via NF-kappaB in the nervous system", Biochim Biophys Acta, 1745, pp.287~299 (2005)
  24. Kansara M, "Molecular pathogenesis of osteosarcoma", DNA Cell Biol, 26, pp.1~18 (2007)
  25. Karin M, "NF-kappaB as a critical link between inflammation and cancer", Cold Spring Harb Perspect Biol, 1, pp.1~14 (2009)
  26. Karlsson EK, "Genome-wide analyses implicate 33 loci inheritable dog Osteosarcoma, including regulatory variants near CDKN2A", B, 2013, pp.14, 1~15
  27. Kelly AD, "MicroRNA paraffinbased studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32", Genome Med, 5, pp.1~12 (2013)
  28. Kim SW, "MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)", Proc Natl Acad Sci USA, 109, pp.7865~7870 (2012)
  29. Kobayashi E, "MicroRNA involvement in osteosarcoma", Sarcoma, 2012, pp.1~8 (2012)
  30. Li T, "HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination", Cell Death Dis, 5, pp.e1229~ (2014)
  31. Lin A, "Cell signaling review series", Cell Res, 18, pp.327~ (2008)
  32. Lin SC, "The ability of CD40L, but not lipopolysaccharide, to initiate immune globulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB", Rel proteins, 1998, pp.18, 5523~5532
  33. Liu CJ, "MiR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas", Ann. Surg. Oncol, 20, pp.S406~S414 (2013)
  34. Liu ZL, "Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K", Akt signaling pathway in vitro, 2013, pp.7, 608~612
  35. Longhi A, "Primary bone OS in the pediatric age: state of threat", Cancer Treat Rev, 32, pp.423~436 (2006)
  36. Mattson MP, "NF-κB in neuronal plasticity and neurodegenerative disorders", J of Clin Invest, 107, pp.247~254 (2001)
  37. Mendell JT, "MicroRNAs in stress signaling and human disease", Cell, 148, pp.1172~1187 (2012)
  38. Minakhina S, "Nuclear factor-kappa B pathways in Drosophila", Oncogene, 25, pp.6749~6757 (2006)
  39. Mitchell PS, "Circulating microRNAs as stable blood-based markers for cancer detection", Proc Natl Acad Sci USA, 105, pp.10513~10518 (2008)
  40. Namløs HM, "Modulation of the Osteosarcoma expression phenotype by microRNAs", PLoS One, 7, pp.e48086~ (2012)
  41. "Understanding Cancer Series - National Cancer Institute" (2014)[URL]
  42. O’Sullivan B, "NF-κB as a therapeutic target in autoimmune disease", Expert Opin Ther Targets, 11, pp.111~122 (2007)
  43. Oeckinghaus A, "Crosstalk in NF-κB signaling pathways", Nature Immun, 12, pp.695~708 (2011)
  44. Olarerin-George AO, "A functional genomics screen for microRNA regulators of NF-kappaB signaling", BMC Biol, 11, pp.1~16 (2013)
  45. Ougang L, "A three-plasma miRNA signature serves as novel biomarker for osteosarcoma", Med Oncol, 30, pp.340~ (2013)
  46. Papa S, "Mechanisms of liver disease: The crosstalk between the NF-κB and JNK pathways", Biol Chem, 390, pp.965~976 (2009)
  47. Perkins ND, "Integrating cell-signaling pathways with NF-kappaB and IKK function", Nat Rev Mol Cell Biol, 8, pp.49~62 (2007)
  48. Pham CG, "Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs", Mol Cell Biol, 27, pp.3920~3935 (2007)
  49. Poos K, "How MicroRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation", PLoS Comput Biol, 9, pp.1~13 (2013)
  50. Pujari R, "A20-mediated negative regulation of canonical NF-κB signaling pathway", Immunol Res, 57, pp.166~171 (2013)
  51. Rahman MM, "Modulation of NF-κB signaling by microbial pathogens", Nat Rev Microbiol, 9, pp.291~306 (2011)
  52. Rieser E, "Linear ubiquitination:a newly discovered regulator of cell signaling", Trends Biochem Sci, 38, pp.94~102 (2013)
  53. Sakuda S, "NF-kappaB activation in nonparenchymal liver cells after partial hepatectomy in rats: possible involvement in expression of heparinbinding epidermal growth factor-like growth factor", J Hepatol, 36, pp.527~533 (2002)
  54. Sakurai T, "Loss of hepatic NF-kappa B activity enhances chemical heaptocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation", Proc Natl Acad Sci USA, 103, pp.10544~10551 (2006)
  55. Shimada M, "MicroRNA-mediated regulation of apoptosis in osteosarcoma", J Carcinogene Mutagene, S6, pp.1~4 (2013)
  56. Silverman N, "NF-κB signaling pathways in mammalian and insect innate immunity", Genes Dev, 15, pp.2321~2342 (2001)
  57. Smida J, "Genomic alterations and allelic imbalances are strong prognostic predictors in Osteosarcoma", Clin Cancer Res, 16, pp.4256~4267 (2010)
  58. Solt LA, "Interleukin-1-induced NF-κB activation is NEMO-dependent but does not require IKK", J Biol Chem, 282, pp.8724~8733 (2007)
  59. Song L, "MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATb", Arch Biochem Biophys, 535, pp.128~135 (2013)
  60. Stiller CA, "International patterns of cancer incidence in adolescents", Cancer Treat Rev, 33, pp.631~645 (2007)
  61. Sun B, "NF-κB signaling, liver disease and hepatoprotective agents", Oncogene, 27, pp.6228~6244 (2008)
  62. Sun SC, "Non-canonical NF-κB signaling pathway", Cell Research, 21, pp.71~85 (2011)
  63. Tan G, "NF-κBdependent microRNA-125b upregulation promotes cell survival by targeting p38α upon UV radiation", J Biol Chem, 287, pp.33036~33047 (2012)
  64. Tang QL, "Glycogen synthase Kinase-3β, NF-κB signaling and tumorigenesis of human osteosarcoma", J Natl Cancer Inst, 104, pp.1~15 (2012)
  65. Thayanithy V, "Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma", Bone, 50, pp.171~181 (2012)
  66. Uwe S, "Anti-inflammatory interventions of NF-κB signaling: Potential applications and risks", Biochem Pharmacol, 75, pp.1567~1579 (2008)
  67. Vallabhapurapu S, "Regulation and function of NF-κB transcription factors in the immune system", Annu Rev Immunol, 27, pp.693~733 (2009)
  68. Vigorita VJ, "Orthopaedic Pathology" (2008), Lippincott, Williams & Wilkins
  69. Wang CY, "NF-κB antiapoptosis: induction of TRAF1and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8activation", Science, 281, pp.1680~1683 (1998)
  70. Won KY, "MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma", Hum Pathol, 44, pp.1648~1655 (2013)
  71. Wu CJ, "Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation", Nat Cell Biol, 8, pp.398~406 (2006)
  72. Wu X, "MicroRNA-34a inhibits fuman osteosarcoma proliferation by downregulating ether à go-go 1 expression", Int J Med Sci, 10, pp.676~682 (2013)
  73. Xia JT, "MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling", J Transl Med, 12, pp.1~12 (2014)
  74. Yin JQ, "The glycogen synthase kinase-3β", nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells, 2013, pp.218, 129~136
  75. Zhang C, "Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with OSs", Int J Mol Sci, 15, pp.6544~6555 (2014)
  76. Zhang H, "MicroRNA-143, down-regulated in Osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2", Oncol Rep, 24, pp.1363~1369 (2010)
  77. Zhang L, "Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation", Nature, 481, pp.204~208 (2012)
  78. Zhao H, "MiR-133b Is down-regulated in human OS and inhibits osteosarocma cells proliferation, migration and invasion, and promotes apoptosis", PLoS One, 8, pp.e83571~ (2013)
  79. Zhao N, "MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3", Mol Cancer, 13, pp.1~11 (2014)
  80. Zhou G, "MicroRNAs in Osteosarcoma: From biological players to clinical contributors, a review", J Int Med Res, 41, pp.1~12 (2013)
  81. Zhou Y, "MiR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST", J Exp Clin Cancer Res, 33, pp.12~ (2014)
  82. Ziyan W, "Micro RNA-21 is involved in osteosarcoma cell invasion and migration", Med Oncol, 28, pp.1469~1474 (2011)

관련 논문AI추천

Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human OsteosarcomaLiqi Wu, Lugen Li, Penghuan Wu, Wenhu Li, Wenxing Lan, Xiangyuan Wen, Xianliao Zhang, Xiaohong Liao, Xiao Wei, Xinhua Xi, Yufa Li, Zhengbo Hu대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in OsteosarcomaBei Gao, Chao Zhang, Lijun Yu, Min Meng, Rina Sa, Wenyuan Luo, Yun Bao연세대학교의과대학 · Yonsei Medical Journal2019 · 제60권 제9호Knockdown of Long Non-Coding RNA NEAT1 Inhibits Proliferation and Invasion and Induces Apoptosis of Osteosarcoma by Inhibiting miR-194 ExpressionHeping Wang, Leifeng Luo, Shuxin Fan, Yanzhang Yu연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제6호The role of microRNAs in cell death pathways이태진, 장지훈영남대학교 의과대학 · Journal of Yeungnam Medical Science2021 · 제38권 제2호Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 ExpressionGang Li, Keyu Liu, Xinhui Du연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제2호Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL AxisCheng-Zhi Zhan, Hua You, Ling Chen, Rui Yao, Tao Wang연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제1호

이 간행물의 다른 논문 (14건)